Oddo BHF maintains its 'outperform' rating on Virbac shares, with an unchanged target price of 385 euros.

Virbac published its results yesterday. The analyst praises the management's presentation, with "a builder's discourse for the medium term".

We found management's tone very encouraging", says Oddo BHF, referring in particular to the company's two latest "highly complementary" acquisitions (Globion and Sassaeah) and positive market trends.

All in all, "the company has the image of a group offering good visibility, with a clear roadmap (guidance 2024 and guidance 2030)", stresses the broker.

Oddo BHF is convinced that the Group should raise its 2024 guidance.

Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.